| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) | 
|---|
| 10/24/2002 | US20020156285 Novel herbicides  | 
| 10/24/2002 | US20020156274 Process for preparing maytansinol  | 
| 10/24/2002 | US20020156273 Streptogramin derivatives, their preparation and compositions which contain them  | 
| 10/24/2002 | US20020156015 Reversal of multidrug resistance in human colon carcinoma cells  | 
| 10/24/2002 | DE10148598A1 New N-(acylaminophenyl)-heteroaryl-benzenesulfonamide derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections  | 
| 10/24/2002 | CA2443697A1 1,4-disubstituted benzo-fused compounds  | 
| 10/24/2002 | CA2443477A1 New process for the preparation of oxabispidines  | 
| 10/24/2002 | CA2443475A1 New process for the preparation of oxabispidines  | 
| 10/24/2002 | CA2443473A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds  | 
| 10/24/2002 | CA2443470A1 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds  | 
| 10/24/2002 | CA2443464A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds  | 
| 10/23/2002 | EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them  | 
| 10/23/2002 | EP1250340A1 Methods and compounds for inhibiting mrp1  | 
| 10/23/2002 | EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants  | 
| 10/23/2002 | EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound  | 
| 10/23/2002 | EP1250135A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders  | 
| 10/23/2002 | EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof  | 
| 10/23/2002 | CN1376031A 除草组合物 Herbicidal compositions  | 
| 10/23/2002 | CN1093130C Substituted pyrido 6,6-bicyclic derivatives  | 
| 10/22/2002 | US6467687 Embossed card package production system with verification system and method  | 
| 10/17/2002 | WO2002081482A1 Compounds and methods for inhibiting mrp1  | 
| 10/17/2002 | WO2002081481A1 Compounds and methods for inhibiting mrp1  | 
| 10/17/2002 | WO2002081480A1 Compounds and pharmaceutical compositions for inhibiting mrp1  | 
| 10/17/2002 | WO2002066468A3 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands  | 
| 10/17/2002 | WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails  | 
| 10/17/2002 | US20020151721 Novel azetidine derivative and process for preparation thereof  | 
| 10/17/2002 | US20020151720 Naphthol derivatives  | 
| 10/17/2002 | US20020151713 Substituted 6,5-hetero-bicyclic derivatives  | 
| 10/17/2002 | CA2442605A1 Compounds and methods for inhibiting mrp1  | 
| 10/17/2002 | CA2442530A1 Compounds and methods for inhibiting mrp1  | 
| 10/17/2002 | CA2442141A1 Compounds and pharmaceutical compositions for inhibiting mrp1  | 
| 10/16/2002 | EP1248784A1 Condensed azepines as vasopressin agonists  | 
| 10/16/2002 | EP0891365B1 Benzoxazines for enhancing synaptic responses  | 
| 10/16/2002 | EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient  | 
| 10/16/2002 | CN1374953A Aromatic nitrogenous six-membered ring compounds  | 
| 10/16/2002 | CN1374872A Stabilization of macrolides  | 
| 10/15/2002 | US6465491 6-phenylpyridyl-2-amine derivatives  | 
| 10/15/2002 | US6465472 Substituted quinazolines and analogs and use thereof  | 
| 10/10/2002 | WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same  | 
| 10/10/2002 | WO2002051413A3 Macrocyclic anti-viral compounds  | 
| 10/10/2002 | WO2002024706A3 Water soluble rapamycin esters  | 
| 10/10/2002 | US20020147362 Synthesis of 2-Hydroxymethylglutamic acid and congeners thereof  | 
| 10/10/2002 | US20020147341 Kinase inhibitor; benign prostatic hyperplasia  | 
| 10/10/2002 | CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same  | 
| 10/09/2002 | EP1246823A1 Pyrimidine and triazine kinase inhibitors  | 
| 10/09/2002 | EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles  | 
| 10/09/2002 | CN1373764A Method for separating lactone-contg. high-molecular weight compounds  | 
| 10/08/2002 | US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators  | 
| 10/06/2002 | WO2003088897A2 Fab i inhibitors  | 
| 10/06/2002 | CA2444597A1 Fab i inhibitors  | 
| 10/03/2002 | WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors  | 
| 10/03/2002 | WO2002076375A2 Process for the preparation of benazepril  | 
| 10/03/2002 | US20020143041 Streptogramin derivatives, their preparation and compositions which contain them  | 
| 10/03/2002 | US20020143013 Thioxazinoquinolones as antiviral agents  | 
| 10/03/2002 | US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92  | 
| 10/03/2002 | US20020142000 Genetic engineering  | 
| 10/03/2002 | CA2442573A1 Process for the preparation of benazepril  | 
| 10/02/2002 | EP1245571A1 Benzbisazole compound and optical recording medium containing the compound  | 
| 10/02/2002 | EP1245550A1 Novel selective deacetylating agents  | 
| 10/02/2002 | EP1244800A1 Rapamycin analogs  | 
| 10/02/2002 | EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring  | 
| 10/02/2002 | CN1372549A Fungicidies  | 
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection  | 
| 10/01/2002 | US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an  | 
| 10/01/2002 | CA2059708C Indole derivatives  | 
| 09/26/2002 | WO2002074775A1 Process for preparing maytansinol  | 
| 09/26/2002 | WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors  | 
| 09/26/2002 | WO2002062796A8 Epindolidione pigments  | 
| 09/26/2002 | WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof  | 
| 09/26/2002 | WO2000043375A3 Substituted aryl heterocyclic compounds  | 
| 09/26/2002 | US20020137733 Macrocyclic anti-viral compounds  | 
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors  | 
| 09/25/2002 | EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof  | 
| 09/25/2002 | EP0912184B1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction  | 
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues  | 
| 09/25/2002 | EP0753297B1 Lotion  | 
| 09/25/2002 | EP0746556B1 Tricyclic compounds having affinity for the 5-ht1a receptor  | 
| 09/25/2002 | CN1371379A New indolocarbazole alkaloids from marine actinomycete  | 
| 09/25/2002 | CN1371378A 28-epirapalogs  | 
| 09/25/2002 | CN1371375A Tricycle dcompounds having spiro union  | 
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines  | 
| 09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family  | 
| 09/24/2002 | US6455521 Psychological disorders; side effect reduction  | 
| 09/19/2002 | WO2002072049A1 Medicinal compositions for stimulating hair growth  | 
| 09/19/2002 | WO2001016139A9 Androgen receptor modulator compounds and methods  | 
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis  | 
| 09/19/2002 | US20020132826 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors  | 
| 09/19/2002 | US20020132824 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction  | 
| 09/19/2002 | US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto  | 
| 09/18/2002 | EP1239868A2 Use of an immunosuppressant for increasing an antifungal activity of a lipopetide  | 
| 09/18/2002 | EP1097155B1 Photochromic six-membered heterocyclic-fused naphthopyrans  | 
| 09/18/2002 | EP0893996B1 Use of a rapamycin derivative in vasculopathies and xenotransplantation  | 
| 09/18/2002 | EP0764158B1 Benzopyrans and their use as therapeutic agents  | 
| 09/18/2002 | CN1370176A Subsstituted heterocycle fused gamma-carbolines  | 
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones  | 
| 09/18/2002 | CN1370169A Substituted heterocycle fused gamma-carbolines  | 
| 09/18/2002 | CN1369493A Process for quickly synthesizing photochromic spirooxazine by microwave  | 
| 09/17/2002 | US6451988 An azo compound and a metal complex which are synthesized with the naphthol derivative  | 
| 09/17/2002 | US6451786 Tyrosine kinase inhibitors  | 
| 09/17/2002 | CA2116674C Imidazolidyl macrolides  |